Bangwei Cao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bangwei Cao has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Changqing Xu
Department of Gastroenterology, Qianfoshan Hospital, Shandong Province, China
2 shared publicationsFang Hou
Department of Anti‐Infection and Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China
1 shared publicationHong Cui
Peking University First Hospital
1 shared publicationHongli Yang
Shandong Provincial Qianfoshan Hospital
1 shared publicationHuimin Qi
Department of Anti‐Infection and Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China
1 shared publicationKun Li
Shandong Provincial Qianfoshan Hospital
1 shared publication
Latest Publications
- 3 September 2009
- Published by Wiley in Liver International
- Vol. 29 (9) , 1383-1388
The haplotype of the MxA gene promoter is associated with hepatitis B virus infection in a Chinese population
Background/Aim: The Myxovirus resistance protein A gene (MxA) is a key component of the innate antiviral response and has previously been shown to inhibit several viruses. This study was designed to assess whether the haplotype in the MxA promoter region was associated with hepatitis B virus (HBV) infection in a Chinese population.Methods: Three hundred and twelve HBV‐infected patients and 317 healthy volunteers were enrolled in this study. Two polymorphisms of −88 and −123 located in the MxA gene promoter were identified by the polymerase chain reaction‐restriction fragment length polymorphism method.Results: The individual possessing haplotype GA, which was constructed by the two polymorphisms of −88G and −123A in the MxA gene promoter, was significantly associated with HBV infection [possessing one copy odds ratio (OR)=1.69, 95% confidence interval (CI) 1.21–2.35; two copy OR=2.84, 95% CI 1.12–7.21 respectively].Conclusions: This case–control study suggested that the haplotype GA in the MxA gene promoter region would increase the susceptibility to HBV infection in a Chinese population.
- 3 September 2009
- Published by Wiley in Liver International
- Vol. 29 (9) , 1383-1388
The haplotype of the MxA gene promoter is associated with hepatitis B virus infection in a Chinese population
Background/Aim: The Myxovirus resistance protein A gene (MxA) is a key component of the innate antiviral response and has previously been shown to inhibit several viruses. This study was designed to assess whether the haplotype in the MxA promoter region was associated with hepatitis B virus (HBV) infection in a Chinese population.Methods: Three hundred and twelve HBV‐infected patients and 317 healthy volunteers were enrolled in this study. Two polymorphisms of −88 and −123 located in the MxA gene promoter were identified by the polymerase chain reaction‐restriction fragment length polymorphism method.Results: The individual possessing haplotype GA, which was constructed by the two polymorphisms of −88G and −123A in the MxA gene promoter, was significantly associated with HBV infection [possessing one copy odds ratio (OR)=1.69, 95% confidence interval (CI) 1.21–2.35; two copy OR=2.84, 95% CI 1.12–7.21 respectively].Conclusions: This case–control study suggested that the haplotype GA in the MxA gene promoter region would increase the susceptibility to HBV infection in a Chinese population.
- 25 May 2007
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 27 (5) , 534-541
Genetic Polymorphisms of LMP/TAP Gene and Hepatitis B Virus Infection Risk in the Chinese Population
Despite the availability of effective vaccines, hepatitis B virus (HBV) infection is still commonly seen worldwide. Several reports show that the human major histocompatability complex (MHC) systems were involved in the elimination of HBV via the restrictive antigen-processing pathway. We investigate whether LMP/TAP gene polymorphisms coded by MHC-II region were associated with HBV infection. A total of seven polymorphisms of LMP/TAP gene were identified by polymerase chain reaction (PCR) restriction fragment length polymorphism (RFLP) assays. Three hundred fifty-six patients and 326 unrelated healthy volunteers were included in the case-control study. Of the seven polymorphisms, three of which (LMP7 codons 145, TAP1 codons 637, and TAP2 codons 651) were observed to have statistically significant association with HBV infection (P < 0.05). We analyzed the three-locus haplotype constructed with three such polymorphisms and found that the frequency of haplotypes D and E increased significantly in patients, in comparison with that in controls (OR = 3.57, 95% CI: 2.09–6.12, P < 0.001; OR = 2.74, 95% CI: 1.35–5.56, P = 0.005, respectively). The results imply that LMP7-145, TAP1-637, and TAP2-651 sites were associated with the risk of HBV infection. Haplotypes D and E might be involved in the development of HBV infection. These data suggest a potential role of LMP/TAP gene as a candidate gene for susceptibility to HBV infection.
- 25 May 2007
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 27 (5) , 534-541
Genetic Polymorphisms of LMP/TAP Gene and Hepatitis B Virus Infection Risk in the Chinese Population
Despite the availability of effective vaccines, hepatitis B virus (HBV) infection is still commonly seen worldwide. Several reports show that the human major histocompatability complex (MHC) systems were involved in the elimination of HBV via the restrictive antigen-processing pathway. We investigate whether LMP/TAP gene polymorphisms coded by MHC-II region were associated with HBV infection. A total of seven polymorphisms of LMP/TAP gene were identified by polymerase chain reaction (PCR) restriction fragment length polymorphism (RFLP) assays. Three hundred fifty-six patients and 326 unrelated healthy volunteers were included in the case-control study. Of the seven polymorphisms, three of which (LMP7 codons 145, TAP1 codons 637, and TAP2 codons 651) were observed to have statistically significant association with HBV infection (P < 0.05). We analyzed the three-locus haplotype constructed with three such polymorphisms and found that the frequency of haplotypes D and E increased significantly in patients, in comparison with that in controls (OR = 3.57, 95% CI: 2.09–6.12, P < 0.001; OR = 2.74, 95% CI: 1.35–5.56, P = 0.005, respectively). The results imply that LMP7-145, TAP1-637, and TAP2-651 sites were associated with the risk of HBV infection. Haplotypes D and E might be involved in the development of HBV infection. These data suggest a potential role of LMP/TAP gene as a candidate gene for susceptibility to HBV infection.